NVO, FDX, SBUX and more
Check out the companies making headlines before the bell. Novo Nordisk – Shares plunged more than 19% after the Danish pharmaceutical giant reported disappointing late-stage trial results for its experimental weight loss drug, CagriSema. Rival obesity drug maker Eli Lilly rose more than 6% following the results. FedEx –...